Bizarre Patents
A hand wearable body squeegee comprising a glove portion, a concave squeegee band, and a linear squeegee band.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7431936 | Proteins involved in cytoadhesion of plasmodium falciparum ring-stage-infected erythrocytes, antibodies which bind to the proteins, and methods for detecting infection, stage of infection and vaccines for protecting against infection The present invention provides the RSP-1 and RSP-2 proteins which are involved in the cytoadhesion of P. falciparum during ring-stage infection of erythrocytes, antibodies which bind to the proteins, methods of screening for a P. falciparum infection, ... | 10/07/2008 |
| 7404960 | Multivalent vaccine composition having increased stability of capsular polysaccharide A vaccine composition comprising two valences is provided: (i) a first valence which is adjuvant-enhanced with aluminum hydroxide and (ii) a second valence which contains a polysaccharide of bacterial capsule comprising one or more o-acetyl groups and which is not a... | 07/29/2008 |
| 7226608 | Topical use of microfine calcined alumina Dispersions containing from about 0.5% to about 30% by weight dispersed microfine calcined alumina, stainless steel, or gold particles typically having particle size of less than about 5μ, more narrowly 1μ or less, suspended in a cosmetically acceptable carrier ar... | 06/05/2007 |
| 7037512 | Topical use of microfine calcined alumina Dispersions containing from about 0.5% to about 30% by weight dispersed microfine calcined alumina, stainless steel, or gold particles typically having particle size of less than about 5μ, more narrowly 1μ or less, suspended in a cosmetically acceptable carrier ar... | 05/02/2006 |
| 7029705 | Nasal hygiene method and composition A method is disclosed of practicing nasal hygiene comprising the steps of applying to a person's nostril a non-irritating hygienic composition consisting essentially of a product of compounding under homogenizing conditions water, 0.01% to 5% by weight, as chlorine ... | 04/18/2006 |
| 6964782 | Stable hydrogen peroxide compositions, products and methods of use Disclosed are several preferred embodiments of hydrogen peroxide which are packaged with ease of use and extended shelf-life in mind. The embodiments include foam, mist, gel, and disposable towelette forms of H2O2. Optional ingredients of topic... | 11/15/2005 |
| 6958159 | Pharmaceutical gel composition The present invention relates to an improved pharmaceutical composition useful for the topical treatment of burns, cuts, wounds, abrasions and the like, and to methods of treatment of injured body surfaces such as skin. ... | 10/25/2005 |
| 6953565 | Process for producing ammonium polythimolybdate A process for producing an ammonium polythiomolybdate of the formula (NH4)2Mo3S13.n H2O where n is 0, 1 or 2 in which an aqueous ammoniacal molybdate solution is reacted with hydrogen sulfide gas in a closed sys... | 10/11/2005 |
| 6951651 | CTL epitope analogs We have screened the HCMV-specific T cell clone, 33F4, with a nonamer PS-SCL based on SEQ ID NO: 1, and described a series of analog peptides that are recognized with greater affinity than the native peptide sequence. ... | 10/04/2005 |
| 6943197 | Topical administration of pharmacologically active bases in the treatment of inflammatory dermatoses Provided are methods and topical pharmaceutical formulations for the treatment of inflammatory dermatoses. The invention involves the topical administration of a pharmacologically active base in a formulation having a pH of about 7.5 to about 13.0, preferably about ... | 09/13/2005 |
| 6905712 | Vaccine adjuvants comprising ginseng plant extract and added aluminum salt A composition, which includes ingredients capable of enhancing the immunogenic effect of a vaccine, includes an aluminium salt and at least one ginsenoside, such as a tri-terpenoid glycoside, preferably a tri-terpenoid glycoside of the structure of Rb1. In one parti... | 06/14/2005 |
| 6846837 | Topical administration of basic antifungal compositions to treat fungal infections of the nails Methods and topical pharmaceutical formulations are provided for the treatment of nail fungus (onychomycosis). The invention involves a pharmacologically active antifungal agent, plus a pharmaceutically acceptable base in a formulation having a pH of 7.5 to about 13... | 01/25/2005 |
| 6827766 | Decontaminating systems containing reactive nanoparticles and biocides Improved area decontamination products and methods of use thereof are provided which include reactive nanoparticles (e.g., metal oxides, hydroxides and mixtures thereof) with one or more biocides and a liquid carrier for the nanoparticles and biocide(s). The product... | 12/07/2004 |
| 6793923 | Vaccines with enhanced immune response and methods for their preparation The present invention is concerned with vaccines and their preparation. An effective long-term immune response, especially in mammals, can be produced using a vaccine comprising an antigen encapsulated in liposomes, a suitable adjuvant and a carrier comprising a con... | 09/21/2004 |
| 6764682 | Adjuvant compositions containing more than one adjuvant Adjuvant compositions for modulating an immune response to an antigen administered to a host comprise a mineral salt adjuvant and at least one other adjuvant. The compositions provide an adjuvanting effect on an antigen which is greater than the adjuvanting effect a... | 07/20/2004 |
| 6696065 | Acellular pertussis vaccines and methods of preparation thereof A multi-component vaccine composition is described comprising acellular pertussis vaccine components, diphtheria toxoid, tetanus toxoid and inactivated poliovirus. The composition also may contain a conjugate of a capsular polysaccharide on Haemophilus in... | 02/24/2004 |
| 6692775 | Bactericidal gel and method for treating burns and dermal lesions A gel formulation is combined with a bactericidal concentrate which is a liquid mixture of about 1000 parts by volume of ultra pure water having an electrical resistance of 16-26 megohms, total dissolved solids of less than 0.04 parts per million and a sp... | 02/17/2004 |
| 6689392 | Methods and compositions for controlling plant pathogen A composition for controlling growth of pathological organisms on a plant, said composition comprises an effective amount of one or more of metal ion(s); one or more of chelating agent(s); and phosphorous acid, and/or salt or hydrate thereof, said composi... | 02/10/2004 |
| 6685969 | Treatment for ectoparasites Ectoparasites, such as fleas, ticks, mites and lice, are removed from a human or animal host after applying a composition that causes the temperature of the treated area to become higher or lower than normal. In one embodiment, treatment is effected by ap... | 02/03/2004 |
| 6663892 | Multiple portion tablet A solid orally administrable pharmaceutical dosage form for the treatment of gastric disorders includes a first portion containing a therapeutically effective amount of a histamine H2 -receptor antagonist, and a second portion immediately adjac... | 12/16/2003 |
| 6630161 | Adjuvant composition and methods for its use An adjuvant composition which is a stable oil-in-water emulsion comprising a metabolizable oil, one or more surfactants, an antioxidant and a compound to make the emulsion isotonic is described and claimed. The stable emulsion has a hydrophobic-lipophilic... | 10/07/2003 |
| 6572861 | Adjuvants for use in vaccines The invention relates to adjuvants that contain a lecithin, an oil and an amphiphilic surfactant and that are capable of forming a stable oil-in-water emulsion vaccine so as to minimize local reactions to the vaccine in the injected animal.... | 06/03/2003 |
| 6541421 | Buffered phosphorus containing solution This invention relates to a buffered phosphorus containing solution comprising at least one phosphorus compound selected from the group consisting of phosphorous acid, hypophosphorous acid, polyphosphorous acid polyhypophosphorous acid, and salts thereof.... | 04/01/2003 |
| 6541038 | Method for treating wood with a metal-containing treating agent and wood treated thereby A method for treating wood, characterized by impregnating wood with a metal-containing treating agent containing lignin and/or lignin derivatives and a metal, a metal compound, and/or a metal ion and oxidizing and/or macromolecularizing of the lignin and/... | 04/01/2003 |
| 6528077 | Cataplasms containing vitamin C or its derivative A cataplasm comprising crosslinked polymer gel containing vitamin C or a derivative thereof and a support, wherein the gel is formed by crosslinking a polymer with two kinds of substances selected from magnesium aluminometasilicate, dried aluminum hydroxi... | 03/04/2003 |
| 6458343 | Quaternary compounds, compositions containing them, and uses thereof A composition comprising a compound selected from the group consisting of compounds of the following structural formula (1A): ##STR1## and the protonated and quaternized derivatives thereof of the following structural formula (1B): ##STR2## wherein R... | 10/01/2002 |
| 6423348 | Anticoagulant compositions What is shown is an animal blood anticoagulant compound useful in the meat packing industry generally, and in slaughterhouse operations, particularly. The anticoagulant is effective when diluted with water at higher dilution ratios than earlier anticoagul... | 07/23/2002 |
| 6416790 | Bactericidal concentrate and method for treating burns and dermal lesions The concentrate is a liquid mixture of about 1000 parts by volume of ultra pure water having an electrical resistance of 16-26 megohms, total dissolved solids of less than 0.04 parts per million and a specific conductance of less than 0.10 microhmo to abo... | 07/09/2002 |
| 6372223 | Influenza virus vaccine composition This invention describes an influenza virus vaccine containing an influenza virus antigen obtained from a cell culture, with an influenza virus antigen content between 1 μg and 5 μg per dose and aluminum as an adjuvant as well as a method for its prepar... | 04/16/2002 |
| 6350474 | Phosphate composition and its utilization The invention deals with phosphate water solution with cold solidification capacity. Phosphate composition containing iron oxide solution in acid, water, advantages from the following properties; it contains orthophosphorus acid and in addition metal powd... | 02/26/2002 |
| 6103274 | Pharmaceutical, orally applicable composition A pharmaceutical, orally applicable composition is disclosed, whereby the composition contains at least one antacid active substance as well as more than 45% by weight of a sugar and/or sugar alcohol and between 12% and 35% by weight of water. The composi... | 08/15/2000 |
| 6027730 | Herpes simplex vaccine comprising HSV glycoprotein GD and 3 deacylated monophosphoryl lipid A Novel herpes simplex (HSV) vaccine formulations are provided. These comprise HSV glycoprotein gD or immunological fragments in conjunction with 3 Deacylated monophosphoryl lipid A.... | 02/22/2000 |
| 6006754 | Method for measuring fat digestion and absorption formulation to aid in measuring fat absorption A method for measuring fat assimilation, such as fat digestion and fat absorption, in a person is provided comprising feeding the person labeled fat, nonabsorbable marker, and a means for coloring stool; allowing the fat, marker and stool coloring means t... | 12/28/1999 |
| 6001348 | Non-virulent Mycoplasma synoviae and vaccine thereof The present invention provides NAD-independent Mycoplasma synoviae of strain MS1. The invention also refers to microbiological cultures comprising Mycoplasma synoviae of this strain. Next to this, the invention refers to live vaccines derived from these s... | 12/14/1999 |
| 5976578 | Liquid antacid compositions Liquid antacid compositions containing a tri- or di-ester buffer have a reduced final product pH providing for a more efficacious preservative system and better tasting product without compromising to acid neutralization capacity of the antacid.... | 11/02/1999 |
| 5914135 | Liquid antacid compositions Calcium carbonate liquid antacid compositions containing one or more pH adjusting agents to maintain the pH above 9.0, preferably above 9.5. The resultant antacid liquid possesses superior resistance to microbial attack and enhanced taste properties.... | 06/22/1999 |
| 5874065 | Oral anti-acid paste and methods of use The invention describes an oral anti-acid paste comprising anti-acid compound in a slow releasing carrier medium which disperses the anti-acid, and releases the anti-acid from the paste upon contact with the aqueous media such as saliva. The paste can be ... | 02/23/1999 |
| 5874112 | Translucent antacid suspension An essentially translucent antacid composition is formed by an aqueous colloidal aluminum hydroxide gel wherein the average particle size of the aluminum hydroxide is less than about 0.5 microns, preferably less than about 0.1 microns, and more preferably... | 02/23/1999 |
| 5858413 | Antacid composition, substantially free of preservatives A pharmaceutical, oral composition of a liquid to semisolid consistency is disclosed, wherein the composition, substantially free of preservatives, contains at least one antacid active substance as well as more than 45% by weight, a sugar and/or sugar alc... | 01/12/1999 |
| 5840768 | MCC: alginate pharmaceutical suspensions Novel pharmaceutical suspensions comprising a pharmaceutically active ingredient suspended in aqueous media with a suspending agent comprising attrited microcrystalline cellulose coprocessed and at least partially surface coated with a calcium sodium algi... | 11/24/1998 |
